Literature DB >> 14708678

Natural history of hepatitis B.

Giovanna Fattovich1.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 14708678     DOI： 10.1016/s0168-8278(03)00139-9

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  35 in total

1.  Transient elastography for measurement of liver stiffness measurement can detect early significant hepatic fibrosis in Japanese patients with viral and nonviral liver diseases.

Authors:  Noriyuki Obara; Yoshiyuki Ueno; Koji Fukushima; Yu Nakagome; Eiji Kakazu; Osamu Kimura; Yuta Wakui; Osamu Kido; Masashi Ninomiya; Takayuki Kogure; Jun Inoue; Yasuteru Kondo; Masaaki Shiina; Takao Iwasaki; Takeshi Yamamoto; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2008-09-20       Impact factor: 7.527

2.  Economic analysis of the first 20 years of universal hepatitis B vaccination program in Italy: an a posteriori evaluation and forecast of future benefits.

Authors:  Sara Boccalini; Cristina Taddei; Vega Ceccherini; Angela Bechini; Miriam Levi; Dario Bartolozzi; Paolo Bonanni
Journal:  Hum Vaccin Immunother       Date:  2013-02-01       Impact factor: 3.452

Review 3.  Chronic hepatitis B--who should be treated?

Authors:  Carla S Coffin; Samuel S Lee
Journal:  MedGenMed       Date:  2006-03-21

4.  Correlates of susceptibility to hepatitis B among people who inject drugs in Sydney, Australia.

Authors:  Rachel M Deacon; Libby Topp; Handan Wand; Carolyn A Day; Craig Rodgers; Paul S Haber; Ingrid van Beek; Lisa Maher
Journal:  J Urban Health       Date:  2012-10       Impact factor: 3.671

5.  Cost-benefit comparison of two proposed overseas programs for reducing chronic Hepatitis B infection among refugees: is screening essential?

Authors:  Amelia Jazwa; Margaret S Coleman; Julie Gazmararian; La'Marcus T Wingate; Brian Maskery; Tarissa Mitchell; Michelle Weinberg
Journal:  Vaccine       Date:  2015-01-14       Impact factor: 3.641

6.  Use of massively parallel ultradeep pyrosequencing to characterize the genetic diversity of hepatitis B virus in drug-resistant and drug-naive patients and to detect minor variants in reverse transcriptase and hepatitis B S antigen.

Authors:  Mariacarmela Solmone; Donatella Vincenti; Mattia Carlo Felice Prosperi; Alessandro Bruselles; Giuseppe Ippolito; Maria Rosaria Capobianchi
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

7.  No increase in hepatitis B virus (HBV)-specific CD8+ T cells in patients with HIV-1-HBV coinfections following HBV-active highly active antiretroviral therapy.

Authors:  Megan Crane; Sunee Sirivichayakul; J Judy Chang; Anchalee Avihingsanon; Sasiwimol Ubolyam; Supranee Buranapraditkun; Pattarawat Thantiworasit; Fiona Wightman; Stephen Locarnini; Gail Matthews; Gregory J Dore; Kiat Ruxrungtham; Sharon R Lewin
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

8.  Reduced hepatic steatosis is associated with higher risk of hepatocellular carcinoma in chronic hepatitis B infection.

Authors:  Lung-Yi Mak; Rex Wan-Hin Hui; James Fung; Fen Liu; Danny Ka-Ho Wong; Bofei Li; Ka-Shing Cheung; Man-Fung Yuen; Wai-Kay Seto
Journal:  Hepatol Int       Date:  2021-06-21       Impact factor: 6.047

9.  Decreasing disparity in liver transplantation among white and Asian patients with hepatocellular carcinoma : California, 1998-2005.

Authors:  Anthony S Robbins; Michael F Daily; Christopher A Aoki; Moon S Chen; Christoph Troppmann; Richard V Perez
Journal:  Cancer       Date:  2008-10-15       Impact factor: 6.860

Review 10.  Chronic hepatitis B in 2014: great therapeutic progress, large diagnostic deficit.

Authors:  Claus Niederau
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.